A novel assay to detect nucleotide receptor P2X7 genetic polymorphisms influencing numerous innate immune functions

Journal of Endotoxin Research

Volumn 10, Issue 2, 2004, Pages 137-142

  Denlinger, Loren C ^a   Schell, Kathleen ^b   Angelini, Giuditta ^a   Green, Dawn ^a   Guadarrama, Arturo ^a   Prabhu, Usha ^a   Coursin, Douglas B ^a   Hogan, Kirk ^a   Bertics, Paul J ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Genetic polymorphisms; Innate immune functions; Monocyte pore assay; Nucleotide receptor P2X7

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GENOMIC DNA; NUCLEOTIDE; PURINE P2X RECEPTOR;

ALLELE; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; LEUKOCYTE FUNCTION; MODULATION; MOLECULAR MODEL; MONOCYTE; PHENOTYPE;

AMINO ACID SUBSTITUTION; HUMANS; IMMUNITY, NATURAL; LEUKOCYTES; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, PURINERGIC P2;

EID: 2342431309     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805104225004040     Document Type: Article

References (26)

1. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-732.
2. Mira JP, Cariou A, Grall F. et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter stud.. JAMA 1999; 282: 561-568.
3. Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999. 354: 561-563.
4. Ma P, Chen D, Pan J, Do B. Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 2002; 30: 1046-1050.
5. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162: 1028-1032.
6. Barber RC, O'Keefe GE. Characterization of a single nucleotide polymorphism in the lipopolysaccharide binding protein and its association with sepsis. Am J Respir Crit Care Med 2003; 167: 1316-1320.
7. 7 nucleotide receptor: modulation of LPS-induced macrophage signaling and mediator production. Drug Dev Res 2001; 53: 91-104.
8. 7 receptor. J Biol Chem 2001; 276: 11135-11142.
9. 7 gene with tuberculosis in a Gambian population. J Infect Dis 2002; 186: 1458-1462.
10. 7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in LPS-induced cytokine production. J Immunol 2004; Revised MS submitted.
11. Gudipaty L, Humphreys BD, Buell G, Dubyak GR. Regulation of P2X(7) nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol 2001; 280: C943-C953.
12. 7 receptor. J Immunol 2002; 169: 4108-4112.
13. 7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 2001; 167: 1871-1876.
14. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-212.
15. Tonetti M, Sturla L, Giovine M, Benatti U, De Flora A. Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-alpha in lipopolysaccharide-treated RAW 264.7 murine macrophages. Biochem Biophys Res Commun 1995; 214: 125-130.
16. Mehta VB, Hart J, Wewers MD. ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J Biol Chem 2001; 276: 3820-3826.
17. Hu Y, Fisette PL, Denlinger LC et al. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1998; 273: 27170-27175.
18. Fairbairn IP, Stober CB, Kumararatne DS, Lammas DA. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol 2001; 167: 3300-3307.
19. Mizuno K, Okamoto H, Horio T. Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells. Clin Exp Immunol 2001; 126: 151-156.
20. 7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 2001; 166: 6754-6763.
21. 7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol 1999; 163: 1958-1965.
22. Chen JR, Gu BJ, Dao LP, Bradley CJ, Mulligan SP, Wiley JS. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23. Br J Haematol 1999; 105: 181-189.
23. Di Virgilio F, Chiozzi P, Ferrari D et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600.
24. 7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002; 359: 1114-1119.
25. 7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002; 360: 1935-1939.
26. 7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol 2003; 171: 5442-5446.